We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.
Aledade leadership shares three aspects hindering ACO adoption among health plans.
A detailed look at the 22 new payer-provider partnerships created in Q1 this year.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
A look back at this year's Cost to Zero Moonshot panel at the StartUp Health Festival.
Advice on how the healthcare industry can address the pharmaceutical cost problem.
It’s not yet known how blockchain will affect the health market. But is healthcare’s blockchain hype justified or just to be set aside?
What missed opportunities will incumbents one day wish they had taken advantage of? Adopting a new mentality will disrupt the industry from the inside out.
Analysis on the potential effects of cost-sharing reduction payments and pass-through savings.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.